150 related articles for article (PubMed ID: 23082097)
1. Confocal fluorescence imaging enables noninvasive quantitative assessment of host cell populations in vivo following photodynamic therapy.
Mitra S; Mironov O; Foster TH
Theranostics; 2012; 2(9):840-9. PubMed ID: 23082097
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.
Mitra S; Modi KD; Foster TH
J Biomed Opt; 2013 Oct; 18(10):101314. PubMed ID: 23897439
[TBL] [Abstract][Full Text] [Related]
3. Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Chepurna OM; Yakovliev A; Ziniuk R; Nikolaeva OA; Levchenko SM; Xu H; Losytskyy MY; Bricks JL; Slominskii YL; Vretik LO; Qu J; Ohulchanskyy TY
J Nanobiotechnology; 2020 Jan; 18(1):19. PubMed ID: 31973717
[TBL] [Abstract][Full Text] [Related]
4. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.
Belicha-Villanueva A; Riddell J; Bangia N; Gollnick SO
Lasers Surg Med; 2012 Jan; 44(1):60-8. PubMed ID: 22246985
[TBL] [Abstract][Full Text] [Related]
5. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells.
Wu D; Liu Z; Fu Y; Zhang Y; Tang N; Wang Q; Tao L
Oncol Lett; 2013 Oct; 6(4):1111-1119. PubMed ID: 24137473
[TBL] [Abstract][Full Text] [Related]
7. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
[TBL] [Abstract][Full Text] [Related]
8. Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.
Ozturk MS; Rohrbach D; Sunar U; Intes X
Acad Radiol; 2014 Feb; 21(2):271-80. PubMed ID: 24439340
[TBL] [Abstract][Full Text] [Related]
9. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
Wang S; Fan W; Kim G; Hah HJ; Lee YE; Kopelman R; Ethirajan M; Gupta A; Goswami LN; Pera P; Morgan J; Pandey RK
Lasers Surg Med; 2011 Sep; 43(7):686-95. PubMed ID: 22057496
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
11. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
[TBL] [Abstract][Full Text] [Related]
12. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy.
Rong P; Yang K; Srivastan A; Kiesewetter DO; Yue X; Wang F; Nie L; Bhirde A; Wang Z; Liu Z; Niu G; Wang W; Chen X
Theranostics; 2014; 4(3):229-39. PubMed ID: 24505232
[TBL] [Abstract][Full Text] [Related]
13. Imaging a photodynamic therapy photosensitizer in vivo with a time-gated fluorescence tomography system.
Mo W; Rohrbach D; Sunar U
J Biomed Opt; 2012 Jul; 17(7):071306. PubMed ID: 22894467
[TBL] [Abstract][Full Text] [Related]
14. Comparative tumor imaging and PDT Efficacy of HPPH conjugated in the mono- and di-forms to various polymethine cyanine dyes: part - 2.
James NS; Ohulchanskyy TY; Chen Y; Joshi P; Zheng X; Goswami LN; Pandey RK
Theranostics; 2013; 3(9):703-18. PubMed ID: 24019855
[TBL] [Abstract][Full Text] [Related]
15. In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6.
Mitra S; Foster TH
Neoplasia; 2008 May; 10(5):429-38. PubMed ID: 18472960
[TBL] [Abstract][Full Text] [Related]
16. Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
Liu Z; Wang Q; Fan L; Wu DP; Zhang Y; Liu L; Tao L
Lasers Surg Med; 2015 Jan; 47(1):68-76. PubMed ID: 25483871
[TBL] [Abstract][Full Text] [Related]
17. Establishment and comparison of three novel methods for the determination of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in human serum.
Chen L; Xiao Q; Zhang X; Yang J
J Pharm Biomed Anal; 2016 Mar; 121():13-21. PubMed ID: 26773535
[TBL] [Abstract][Full Text] [Related]
18. Image-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigation.
Sajisevi M; Rigual NR; Bellnier DA; Seshadri M
J Oral Maxillofac Surg Med Pathol; 2015 Mar; 27(2):159-165. PubMed ID: 25750858
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
Sun G; Anderson MA; Gorospe EC; Leggett CL; Lutzke LS; Wong Kee Song LM; Levy M; Wang KK
Lasers Surg Med; 2012 Nov; 44(9):755-61. PubMed ID: 23018618
[TBL] [Abstract][Full Text] [Related]
20. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
